Search results for "Oates"

showing 10 items of 145 documents

Tamibarotene in patients with acute promyelocytic leukaemia relapsing after treatment with all-trans retinoic acid and arsenic trioxide

2015

Treatment of acute promyelocytic leukaemia (APL) with arsenic trioxide (ATO) and all-trans retinoic acid (ATRA) is highly effective first-line therapy, although approximately 5-10% of patients relapse. Tamibarotene is a synthetic retinoid with activity in APL patients who relapse after chemotherapy and ATRA, but has not been studied in relapse after treatment with ATO and ATRA. We report on a phase II study of tamibarotene in adult patients with relapsed or refractory APL after treatment with ATRA and ATO (n = 14). Participants were treated with tamibarotene (6 mg/m(2) /d) during induction and for up to six cycles of consolidation. The overall response rate was 64% (n = 9), the rate of comp…

MaleOncogene Proteins Fusionmedicine.medical_treatmentDrug ResistancePhases of clinical researchSalvage therapyKaplan-Meier EstimatePharmacologyGastroenterologyBenzoatesArsenicalschemistry.chemical_compoundLeukemia Promyelocytic AcuteRecurrenceAntineoplastic Combined Chemotherapy ProtocolsMedicineArsenic trioxidePromyelocyticOncogene ProteinsTumorLeukemiaRemission InductionHematopoietic Stem Cell TransplantationCell DifferentiationOxidesclinical trialHematologyMiddle AgedCombined Modality Therapyall-trans retinoic acidarsenic trioxideLeukemiaCardiovascular DiseasesFemalemedicine.drugAdultmedicine.medical_specialtyTetrahydronaphthalenesAcute promyelocytic leukaemia; all-trans retinoic acid; arsenic trioxide; clinical trial; tamibarotene; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenicals; Benzoates; Biomarkers Tumor; Cardiovascular Diseases; Cell Differentiation; Combined Modality Therapy; Consolidation Chemotherapy; Disease-Free Survival; Drug Resistance Neoplasm; Febrile Neutropenia; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Leukemia Promyelocytic Acute; Male; Middle Aged; Oncogene Proteins Fusion; Oxides; Recurrence; Remission Induction; Salvage Therapy; Tetrahydronaphthalenes; TretinoinAntineoplastic AgentsTretinoinAcuteArticleDisease-Free SurvivalTretinoinInternal medicineBiomarkers TumorHumansFusionneoplasmsAgedFebrile NeutropeniaSalvage TherapyChemotherapybusiness.industrymedicine.diseasetamibaroteneAcute promyelocytic leukaemiaConsolidation ChemotherapychemistryDrug Resistance NeoplasmNeoplasmTamibarotenebusinessSettore MED/15 - Malattie del SangueFebrile neutropeniaBiomarkers
researchProduct

Bone marrow characteristics predict outcome in a multicenter cohort of primary immune thrombocytopenia patients treated with thrombopoietin analogs

2019

It is well established that immune thrombocytopenia (ITP) results from increased immune mediated platelet destruction (anti-platelets antibodies, autoreactive T cells, and reduction of regulatory T cells) along with impaired production in the bone marrow.1 The latter has been attributed to both cellular and humoral mediators that cause suppression of megakaryocyte production and maturation.2 Current standard first line therapy consists of corticosteroids, with or without intravenous Ig, achieving about 70-80% response rate. However, a consistent proportion of patients would relapse after corticosteroid discontinuation or tapering, and requires further therapy. ...

MaleOncologymedicine.medical_specialtyRecombinant Fusion ProteinsEltrombopagBone Marrow CellsImmune Thrombocytopenic PurpuraReceptors FcBenzoateschemistry.chemical_compoundInternal medicinemedicineHumansOnline Only ArticlesThrombopoietinRetrospective StudiesPurpura Thrombocytopenic IdiopathicRomiplostimbusiness.industryRetrospective cohort studyromiplostimHematologyMiddle AgedImmune thrombocytopeniaClinical trialHydrazinesmedicine.anatomical_structureThrombopoietinchemistryCohortPyrazolesFemaleBone marroweltrombopagbusinessFollow-Up Studiesmedicine.drugHaematologica
researchProduct

Systolic Blood Pressure Variation and Mean Heart Rate Is Associated With Cognitive Dysfunction in Patients With High Cardiovascular Risk

2015

Abstract— Elevated systolic blood pressure (SBP) correlates to cognitive decline and incident dementia. The effects of heart rate (HR), visit to visit HR variation, and visit to visit SBP variation are less well established. Patients without preexisting cognitive dysfunction (N=24 593) were evaluated according to mean SBP, SBP visit to visit variation (coefficient of variation [standard deviation/mean×100%], CV), mean HR, and visit to visit HR variation (HR-CV) in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease. Cognitive function was assessed with min…

MalePredictive Value of TestAngiotensin-Converting Enzyme InhibitorsBlood PressureBenzimidazoleBenzoatesRamiprilRetrospective StudieHeart RateRisk FactorsCardiovascular DiseaseTelmisartanCognitive declineMultivariate AnalysiRandomized Controlled Trials as TopicAged 80 and overmedicine.diagnostic_testIncidenceMiddle AgedstrokeAntihypertensive Agentmyocardial infarctionCardiovascular DiseasesHypertensionCardiologyDrug Therapy CombinationFemaleHumanmedicine.drugRamiprilmedicine.medical_specialtyBenzoateFollow-Up StudieCognition DisorderPredictive Value of TestsInternal medicineHeart rateInternal MedicinemedicineHumansDementiaAntihypertensive AgentsAgedRetrospective StudiesMini–Mental State Examinationbusiness.industryRisk FactorAngiotensin-Converting Enzyme InhibitorOdds ratiomedicine.diseaseConfidence intervalBlood pressureMultivariate AnalysisPhysical therapyBenzimidazolesCognition DisordersbusinessFollow-Up StudiesHypertension
researchProduct

Kinetic experiments on the synergistic effect of NADH on microsomal drug oxidation.

1974

Abstract1. The synergistic effect of NADH on the NADPH-dependent mixed function oxidation of p-nitroanisole and hexobarbital can be measured both photometrically and by following the substrate-induced oxygen consumption. The increase in reaction rate is about 50% and lasts as long as NADH is present in the microsomal suspension.2. The oxidation of added NADH is increased by hexobarbital, ethylmorphine and SKF 525-A. Lineweaver-Burk transformation of the NADH oxidation rates yields straight lines for xenobiotic substrates suggesting Michaelis constants similar to those obtained from metabolic experiments. NADH oxidation in the absence of NADPH is about half as rapid as in its presence.3. Som…

MalePyridinesHealth Toxicology and MutagenesisCyanidechemistry.chemical_elementHexobarbitalAnisolesToxicologyPhotochemistryBiochemistryOxygenMixed Function Oxygenaseschemistry.chemical_compoundOxygen ConsumptionPhenolsmedicineOrganic chemistryAnimalsPharmacologyCarbon MonoxideAniline CompoundsChemistryProadifenDrug SynergismGeneral MedicineMetyraponeEthylmorphineNADNitro CompoundsRatsHexobarbitalPharmaceutical PreparationsSpectrophotometryReagentPhenobarbitalMicrosomeMicrosomes LiverXenobioticChloromercuribenzoatesOxidation-Reductionmedicine.drugCarbon monoxideXenobiotica; the fate of foreign compounds in biological systems
researchProduct

Targeting metabolomics analysis of the sunscreen agent 2-ethylhexyl 4-(N,N-dimethylamino)benzoate in human urine by automated on-line solid-phase ext…

2011

The in vivo metabolism of the xenobiotic agent 2-ethylhexyl 4-(N,N-dimethylamino)benzoate (EDP), a UV filter commonly used in sunscreen cosmetic products, was studied by targeting metabolomics analysis in human urine. The metabolomic study involved the use of urine from male and female volunteers before and after application of an EDP-containing sunscreen cosmetic. The metabolism of EDP in urine was studied by using the triple quadrupole detector in a combination of Precursor Ion Scanning and Neutral Loss Scanning modes, with and without enzymatic hydrolysis. Detected metabolites were subsequently confirmed as glucuronide conjugates of 4-(N,N-dimethylamino)benzoic acid and 4-(N-methylamino)…

MaleSkin AbsorptionTandem mass spectrometryMass spectrometryBiochemistryHigh-performance liquid chromatographyAnalytical ChemistrySonicationDrug StabilityTandem Mass SpectrometryLiquid chromatography–mass spectrometrypara-AminobenzoatesHumansMetabolomicsSolid phase extractionGlucuronidaseChromatographyChemistryHydrolysisSolid Phase ExtractionOrganic ChemistryGeneral MedicineTriple quadrupole mass spectrometerStandard additionMetabolomeFemaleSulfatasesTime-of-flight mass spectrometry4-Aminobenzoic AcidSunscreening AgentsChromatography LiquidJournal of Chromatography A
researchProduct

The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2)

2012

Observational studies have shown that 24-h and morning ambulatory blood pressure (BP) control is low. This large-scale, practice-based study evaluated the effects of telmisartan 40 or 80 mg alone or in combination with hydrochlorothiazide (HCTZ) 12.5 mg on these BP parameters over 8 weeks; treatment was adjusted if clinic BP remained ≥140/90 mm Hg. A total of 863 patients were evaluated (baseline mean clinic BP, morning and 24-h ambulatory BP: 155±15/93±10 mm Hg, 137±15/83±11 mm Hg, 133±14/79±10 mm Hg, respectively; 68% were previously treated at baseline). Telmisartan with/without HCTZ significantly reduced the mean morning ambulatory BP (-8.2/-4.9 mm Hg), daytime ambulatory BP (-8.0/-4.7 …

Malemedicine.medical_specialtyAmbulatory blood pressureAdolescentPhysiologyAngiotensin-Converting Enzyme InhibitorsBlood PressurePharmacologyBenzoatesYoung AdultHydrochlorothiazideReference ValuesAmbulatory CareInternal MedicinemedicineHumansTelmisartanambulatory blood pressure monitoring hidro hydrochlorothiazide morning blood pressure control telmisartanAntihypertensive AgentsAgedMorningAged 80 and overbusiness.industryMED/11 - MALATTIE DELL'APPARATO CARDIOVASCOLAREBlood Pressure Monitoring AmbulatoryMiddle AgedCircadian RhythmDrug CombinationsHydrochlorothiazideTreatment OutcomeHypertensionAmbulatoryEmergency medicineBenzimidazolesDrug Therapy CombinationFemaleTelmisartanCardiology and Cardiovascular Medicinebusinessmedicine.drugHypertension Research
researchProduct

Long-term use of angiotensin II receptor antagonists and calcium-channel antagonists in Algerian hypertensive patients: Effects on metabolic and oxid…

2015

The effects of calcium antagonists (amlodipine) and angiotensin II receptor antagonists (telmisartan) on lipid profile and oxidative markers were investigated in Algerian hypertensive patients. At the beginning and after 1 year of antihypertensive therapy, blood samples are collected for determination of biochemical parameters (glucose, cholesterol, triglycerides, urea, creatinine) and oxidative markers (malondialdehyde, carbonyl proteins, nitric oxide, superoxide anion, vitamin C, glutathione, catalase, superoxide dismutase). The results of this study indicate that telmisartan and amlodipine are effective antihypertensive agents in the treatment of hypertension because a significant reduct…

Malemedicine.medical_specialtyAngiotensin receptorPharmacologymedicine.disease_causeBenzoatesBiochemistryAngiotensin Receptor Antagonistschemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineHumansTelmisartanAmlodipineAngiotensin Receptor Antagonistsmedicine.diagnostic_testChemistryMiddle AgedCalcium Channel BlockersMalondialdehydeOxidative StressEndocrinologyBlood pressureAlgeriaHypertensionBenzimidazolesFemaleAmlodipineTelmisartanLipid profileOxidative stressmedicine.drugFree Radical Biology and Medicine
researchProduct

Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.

2004

This study analyzed the relationship between four renin–angiotensin system (RAS) gene polymorphisms and the response to blood pressure lowering and development of microalbuminuria in 206 patients with essential hypertension treated once daily for 12 months with telmisartan 80 mg. Seated cuff blood pressure and urinary albumin excretion (UAE) were measured throughout the study. Patients were screened for the presence of the A-6G variant of the angiotensinogen gene, angiotensin-converting enzyme insertion/deletion polymorphism, and the A1166C and C573T polymorphisms of the angiotensin II type 1 receptor gene. No significant association was found between the presence of any gene polymorphism a…

Malemedicine.medical_specialtyBlood PressureEssential hypertensionBenzoatesExcretionRenin-Angiotensin SystemInternal medicineRenin–angiotensin systemGeneticsMedicineAlbuminuriaHumansProspective StudiesTelmisartanAgedPharmacologyPolymorphism Geneticbusiness.industryMiddle Agedmedicine.diseaseAngiotensin IIBlood pressureEndocrinologyHypertensionMolecular MedicineMicroalbuminuriaBenzimidazolesFemaleGene polymorphismTelmisartanbusinessmedicine.drugThe pharmacogenomics journal
researchProduct

Comparison of BT-PABA test and fecal chymotrypsin measurements in normal subjects and diabetic patients

1990

A N-benzoil-L-tyrosil-PABA test on 6h urine collection, a plasma PABA assay 2 h after administration and a fecal chymotrypsin assay were performed on 66 patients (36 controls and 30 type 2 diabetic patients on insulin therapy). All patients were hospitalized and without gastrointestinal and renal disease. The mean values of plasmatic PABA and fecal chymotrypsin were significantly lower in the diabetic group than in the controls (p less than 0.025 and p less than 0.01, respectively), although they remained within normal range. But this was not the case for PABA urinary excretion values. This may indicate a slower but more protracted PABA absorption during the third or fourth hour with the re…

Malemedicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentFecesEndocrinologyUrinary excretionReference ValuesInternal medicineDiabetes mellituspara-AminobenzoatesInternal MedicinePancreatic functionChymotrypsinHumansInsulinMedicineNormal rangeFecal chymotrypsinbusiness.industryInsulinGeneral MedicineMiddle Agedmedicine.diseasePancreatic Function TestsEndocrinologyDiabetes Mellitus Type 2Femalebusiness4-Aminobenzoic AcidUrine collectionActa Diabetologica Latina
researchProduct

Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study

2014

Background and aims: Epidemiologic and biological evidence supports an inverse association between polyphenol consumption and the risk of cardiovascular disease (CVD). However, no previous studies have prospectively evaluated the relationship between polyphenol intake and the incidence of CVD in such a comprehensive way. The aim was to evaluate the association between intakes of total polyphenol and polyphenol subgroups, and the risk of major cardiovascular events (myocardial infarction, stroke or death from cardiovascular causes) in the PREDIMED study. Methods and results: The present work is an observational study within the PREDIMED trial. Over an average of 4.3 years of follow-up, there…

Malemedicine.medical_specialtyInverse AssociationHydroxybenzoic acidFlavonolsEpidemiologyEndocrinology Diabetes and MetabolismMyocardial InfarctionMedicine (miscellaneous)Diet MediterraneanAntioxidantsLignanslaw.inventionCohort StudiesRandomized controlled trialRisk FactorslawInternal medicineHydroxybenzoatesmedicineHumansNutsPlant OilsOlive OilStrokeAgedNutrition and Dieteticsbusiness.industryIncidenceIncidence (epidemiology)Anti-Inflammatory Agents Non-SteroidalAge FactorsPolyphenolsfood and beveragesMiddle Agedmedicine.diseaseConfidence intervalDietStrokeClinical trialCardiovascular diseasesBiochemistrySpainFemaleObservational studyCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesNutrition, Metabolism and Cardiovascular Diseases
researchProduct